Z-VAD-FMK
Contact us: [email protected]
Z-VAD-FMK |
|||
A1902-10 | ApexBio | 10 mg | EUR 408 |
Description: Z-VAD-FMK, an inhibitor of ICE-like proteases, inhibits apoptosis in THP.1 cells induced by diverse stimuli1 and Fas antigen-induced apoptosis in Jurkat T-cells2. |
Z-VAD-FMK |
|||
A1902-25 | ApexBio | 25 mg | EUR 616.8 |
Description: Z-VAD-FMK, an inhibitor of ICE-like proteases, inhibits apoptosis in THP.1 cells induced by diverse stimuli1 and Fas antigen-induced apoptosis in Jurkat T-cells2. |
Z-VAD-FMK |
|||
A1902-5 | ApexBio | 5 mg | EUR 268.8 |
Description: Z-VAD-FMK, an inhibitor of ICE-like proteases, inhibits apoptosis in THP.1 cells induced by diverse stimuli1 and Fas antigen-induced apoptosis in Jurkat T-cells2. |
Z-VAD-FMK |
|||
A1902-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 268.8 |
Description: Z-VAD-FMK, an inhibitor of ICE-like proteases, inhibits apoptosis in THP.1 cells induced by diverse stimuli1 and Fas antigen-induced apoptosis in Jurkat T-cells2. |
Z-VAD-FMK |
|||
HY-16658B | MedChemExpress | 10mg | EUR 786 |
Z-VAD-FMK |
|||
13300 | AAT Bioquest | 1 mg | EUR 102 |
Z-VAD(OMe)-FMK |
|||
HY-16658 | MedChemExpress | 10mg | EUR 472.8 |
Z-VAD-FMK, cell permeable |
|||
GL1523-1MG | Glentham Life Sciences | 1 mg | EUR 330 |
Z-VAD-FMK, cell permeable |
|||
GL1523-5MG | Glentham Life Sciences | 5 mg | EUR 950.4 |
Caspase-Family Inhibitor Z-VAD-FMK |
|||
1010-100 | Biovision | EUR 235.2 |
Caspase-Family Inhibitor Z-VAD-FMK |
|||
1010-20C | Biovision | EUR 235.2 |
SRB-VAD-FMK [Sulforhodamine B-VAD-FMK] |
|||
13472 | AAT Bioquest | 25 Tests | EUR 158.4 |
SRB-VAD-FMK [Sulforhodamine B-VAD-FMK] |
|||
13482 | AAT Bioquest | 100 Tests | EUR 211 |
Z-VAD-FMK (Pan-specific caspase inhibitor) |
|||
SIH-557-1MG | Stressmarq | 1 mg | EUR 231.6 |
Description: The substance Z-VAD-FMK is a pan-specific caspase inhibitor. It is synthetically produced and has a purity of >98%. The pure substance is lyophilized solid or wax which is May be dissolved in DMSO (10 mg/ml). |
Biotin-VAD-FMK |
|||
1123-20C | Biovision | EUR 392.4 |
FAM-VAD-FMK |
|||
13470 | AAT Bioquest | 25 Tests | EUR 158.4 |
TF4-VAD-FMK |
|||
13471 | AAT Bioquest | 25 Tests | EUR 158.4 |
FITC-VAD-FMK |
|||
9497-100 | Biovision | EUR 430.8 |
Biotin-VAD-FMK |
|||
HY-100894 | MedChemExpress | 1mg | EUR 1216.8 |
FAM-VAD-FMK |
|||
13484 | AAT Bioquest | 100 Tests | EUR 211 |
mFluor™ 450-VAD-FMK |
|||
13475 | AAT Bioquest | 25 Tests | EUR 158.4 |
mFluor™ 510-VAD-FMK |
|||
13476 | AAT Bioquest | 25 Tests | EUR 158.4 |
Z-YVAD-FMK |
|||
1141-1 | Biovision | EUR 405.6 |
Z-YVAD-FMK |
|||
1141-5 | Biovision | EUR 966 |
Z-VDVAD-FMK |
|||
1142-1 | Biovision | EUR 366 |
Z-VDVAD-FMK |
|||
1142-5 | Biovision | EUR 966 |
Z-DEVD-FMK |
|||
1143-1 | Biovision | EUR 379.2 |
Z-DEVD-FMK |
|||
1143-5 | Biovision | EUR 966 |
Z-LEVD-FMK |
|||
1144-1 | Biovision | EUR 379.2 |
Z-LEVD-FMK |
|||
1144-5 | Biovision | EUR 966 |
Z-VEID-FMK |
|||
1146-1 | Biovision | EUR 366 |
Z-VEID-FMK |
|||
1146-5 | Biovision | EUR 966 |
Z-IETD-FMK |
|||
1148-1 | Biovision | EUR 392.4 |
Z-IETD-FMK |
|||
1148-5 | Biovision | EUR 940.8 |
Z-LEHD-FMK |
|||
1149-1 | Biovision | EUR 379.2 |
Z-LEHD-FMK |
|||
1149-5 | Biovision | EUR 920.4 |
Z-ATAD-FMK |
|||
1152-1 | Biovision | EUR 418.8 |
Z-ATAD-FMK |
|||
1152-5 | Biovision | EUR 1096.8 |
Z-FA-FMK |
|||
1986-1 | Biovision | EUR 176.4 |
Z-FA-FMK |
|||
1986-5 | Biovision | EUR 444 |
Z-YVAD-FMK |
|||
A8955-1 | ApexBio | 1 mg | EUR 282 |
Description: Z-YVAD-FMK is a potent cell-permeable and irreversible inhibitor of caspase-1.In Caco-2 cells, Z-YVAD-FMK significantly decreased the growth inhibition induced by butyrate. |
Z-YVAD-FMK |
|||
A8955-5 | ApexBio | 5 mg | EUR 616.8 |
Description: Z-YVAD-FMK is a potent cell-permeable and irreversible inhibitor of caspase-1.In Caco-2 cells, Z-YVAD-FMK significantly decreased the growth inhibition induced by butyrate. |
Z-YVAD-FMK |
|||
A8955-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 1326 |
Description: Z-YVAD-FMK is a potent cell-permeable and irreversible inhibitor of caspase-1.In Caco-2 cells, Z-YVAD-FMK significantly decreased the growth inhibition induced by butyrate. |
Z-FA-FMK |
|||
A8170-1 | ApexBio | 1 mg | EUR 142.8 |
Description: Z-FA-FMK is a control peptidic fluoromethylketone (boc-Thr-CH2F), and inhibitor to calpain (Ac-Leu-Leu-norleucinal), cathepsin B (Z-Phe-Ala-CH2F), and CPP32-like proteases (Z-DEVD-CH2F) [1]. |
Z-FA-FMK |
|||
A8170-10 | ApexBio | 10 mg | EUR 560.4 |
Description: Z-FA-FMK is a control peptidic fluoromethylketone (boc-Thr-CH2F), and inhibitor to calpain (Ac-Leu-Leu-norleucinal), cathepsin B (Z-Phe-Ala-CH2F), and CPP32-like proteases (Z-DEVD-CH2F) [1]. |
Z-FA-FMK |
|||
A8170-25 | ApexBio | 25 mg | EUR 616.8 |
Description: Z-FA-FMK is a control peptidic fluoromethylketone (boc-Thr-CH2F), and inhibitor to calpain (Ac-Leu-Leu-norleucinal), cathepsin B (Z-Phe-Ala-CH2F), and CPP32-like proteases (Z-DEVD-CH2F) [1]. |
Z-FA-FMK |
|||
A8170-5 | ApexBio | 5 mg | EUR 338.4 |
Description: Z-FA-FMK is a control peptidic fluoromethylketone (boc-Thr-CH2F), and inhibitor to calpain (Ac-Leu-Leu-norleucinal), cathepsin B (Z-Phe-Ala-CH2F), and CPP32-like proteases (Z-DEVD-CH2F) [1]. |
Z-FA-FMK |
|||
A8170-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 408 |
Description: Z-FA-FMK is a control peptidic fluoromethylketone (boc-Thr-CH2F), and inhibitor to calpain (Ac-Leu-Leu-norleucinal), cathepsin B (Z-Phe-Ala-CH2F), and CPP32-like proteases (Z-DEVD-CH2F) [1]. |
Z-FA-FMK |
|||
A8170-S | ApexBio | Evaluation Sample | EUR 97.2 |
Description: Z-FA-FMK is a control peptidic fluoromethylketone (boc-Thr-CH2F), and inhibitor to calpain (Ac-Leu-Leu-norleucinal), cathepsin B (Z-Phe-Ala-CH2F), and CPP32-like proteases (Z-DEVD-CH2F) [1]. |
Z-DEVD-FMK |
|||
A1920-1 | ApexBio | 1 mg | EUR 135.6 |
Description: Z-DEVD-FMK is a tetrapeptide caspase inhibitor that is considered relatively selective for caspase-31, 2 and has been widely used in in vitro and in vivo models of acute injury to delineate roles for caspase 3 in neuronal cell death. |
Z-DEVD-FMK |
|||
A1920-10 | ApexBio | 10 mg | EUR 408 |
Description: Z-DEVD-FMK is a tetrapeptide caspase inhibitor that is considered relatively selective for caspase-31, 2 and has been widely used in in vitro and in vivo models of acute injury to delineate roles for caspase 3 in neuronal cell death. |
Z-DEVD-FMK |
|||
A1920-25 | ApexBio | 25 mg | EUR 616.8 |
Description: Z-DEVD-FMK is a tetrapeptide caspase inhibitor that is considered relatively selective for caspase-31, 2 and has been widely used in in vitro and in vivo models of acute injury to delineate roles for caspase 3 in neuronal cell death. |
Z-DEVD-FMK |
|||
A1920-5 | ApexBio | 5 mg | EUR 268.8 |
Description: Z-DEVD-FMK is a tetrapeptide caspase inhibitor that is considered relatively selective for caspase-31, 2 and has been widely used in in vitro and in vivo models of acute injury to delineate roles for caspase 3 in neuronal cell death. |
Z-DEVD-FMK |
|||
A1920-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 351.6 |
Description: Z-DEVD-FMK is a tetrapeptide caspase inhibitor that is considered relatively selective for caspase-31, 2 and has been widely used in in vitro and in vivo models of acute injury to delineate roles for caspase 3 in neuronal cell death. |
Z-DEVD-FMK |
|||
A1920-S | ApexBio | Evaluation Sample | EUR 97.2 |
Description: Z-DEVD-FMK is a tetrapeptide caspase inhibitor that is considered relatively selective for caspase-31, 2 and has been widely used in in vitro and in vivo models of acute injury to delineate roles for caspase 3 in neuronal cell death. |
Z-DQMD-FMK |
|||
A1921-1 | ApexBio | 1 mg | EUR 135.6 |
Description: Inhibition of caspase-3 processing by Z-DQMD-FMK (Z-Asp(OMe)-Gln-Met-Asp(OMe)-fluoromethylketone) did not restore cell number in the zinc-deficient group, but resulted in processing of full-length PKC-? to a 56-kDa fragment1. |
Z-DQMD-FMK |
|||
A1921-10 | ApexBio | 10 mg | EUR 408 |
Description: Inhibition of caspase-3 processing by Z-DQMD-FMK (Z-Asp(OMe)-Gln-Met-Asp(OMe)-fluoromethylketone) did not restore cell number in the zinc-deficient group, but resulted in processing of full-length PKC-? to a 56-kDa fragment1. |
Z-DQMD-FMK |
|||
A1921-25 | ApexBio | 25 mg | EUR 616.8 |
Description: Inhibition of caspase-3 processing by Z-DQMD-FMK (Z-Asp(OMe)-Gln-Met-Asp(OMe)-fluoromethylketone) did not restore cell number in the zinc-deficient group, but resulted in processing of full-length PKC-? to a 56-kDa fragment1. |
Z-DQMD-FMK |
|||
A1921-5 | ApexBio | 5 mg | EUR 268.8 |
Description: Inhibition of caspase-3 processing by Z-DQMD-FMK (Z-Asp(OMe)-Gln-Met-Asp(OMe)-fluoromethylketone) did not restore cell number in the zinc-deficient group, but resulted in processing of full-length PKC-? to a 56-kDa fragment1. |
Z-DQMD-FMK |
|||
A1921-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 518.4 |
Description: Inhibition of caspase-3 processing by Z-DQMD-FMK (Z-Asp(OMe)-Gln-Met-Asp(OMe)-fluoromethylketone) did not restore cell number in the zinc-deficient group, but resulted in processing of full-length PKC-? to a 56-kDa fragment1. |
Z-DQMD-FMK |
|||
A1921-S | ApexBio | Evaluation Sample | EUR 97.2 |
Description: Inhibition of caspase-3 processing by Z-DQMD-FMK (Z-Asp(OMe)-Gln-Met-Asp(OMe)-fluoromethylketone) did not restore cell number in the zinc-deficient group, but resulted in processing of full-length PKC-? to a 56-kDa fragment1. |
Z-VDVAD-FMK |
|||
A1922-1 | ApexBio | 1 mg | EUR 212.4 |
Description: Jurkat T-lymphocytes treated with an irreversible caspase-2 inhibitor, benzyloxycarbonyl-Val-Asp(OMe)-Val-Ala-Asp(OMe)-fluoromethyl ketone (Z-VDVAD-FMK), or stably transfected with pro-caspase-2 antisense (Casp-2/AS) are refractory to cytochrome c release stimulated by etoposide1. |
Z-VDVAD-FMK |
|||
A1922-10 | ApexBio | 10 mg | EUR 756 |
Description: Jurkat T-lymphocytes treated with an irreversible caspase-2 inhibitor, benzyloxycarbonyl-Val-Asp(OMe)-Val-Ala-Asp(OMe)-fluoromethyl ketone (Z-VDVAD-FMK), or stably transfected with pro-caspase-2 antisense (Casp-2/AS) are refractory to cytochrome c release stimulated by etoposide1. |
Z-VDVAD-FMK |
|||
A1922-25 | ApexBio | 25 mg | EUR 1173.6 |
Description: Jurkat T-lymphocytes treated with an irreversible caspase-2 inhibitor, benzyloxycarbonyl-Val-Asp(OMe)-Val-Ala-Asp(OMe)-fluoromethyl ketone (Z-VDVAD-FMK), or stably transfected with pro-caspase-2 antisense (Casp-2/AS) are refractory to cytochrome c release stimulated by etoposide1. |
Z-VDVAD-FMK |
|||
A1922-5 | ApexBio | 5 mg | EUR 477.6 |
Description: Jurkat T-lymphocytes treated with an irreversible caspase-2 inhibitor, benzyloxycarbonyl-Val-Asp(OMe)-Val-Ala-Asp(OMe)-fluoromethyl ketone (Z-VDVAD-FMK), or stably transfected with pro-caspase-2 antisense (Casp-2/AS) are refractory to cytochrome c release stimulated by etoposide1. |
Z-VDVAD-FMK |
|||
A1922-S | ApexBio | Evaluation Sample | EUR 97.2 |
Description: Jurkat T-lymphocytes treated with an irreversible caspase-2 inhibitor, benzyloxycarbonyl-Val-Asp(OMe)-Val-Ala-Asp(OMe)-fluoromethyl ketone (Z-VDVAD-FMK), or stably transfected with pro-caspase-2 antisense (Casp-2/AS) are refractory to cytochrome c release stimulated by etoposide1. |
Z-VEID-FMK |
|||
A1923-1 | ApexBio | 1 mg | EUR 212.4 |
Description: When compared to other caspase inhibitors, Z-DRHD-FMK inhibited caspase 6 activity more effectively than the general caspase inhibitor Z-Val-Ala-Asp (OMe)-fluoromethy ketone (Z-VAD-FMK) or the caspase 6 inhibitor Z-Val-Glu(Ome)-Ile-Asp(OMe)-fluoromethyl ketone (Z-VEID-FMK). |
Z-VEID-FMK |
|||
A1923-10 | ApexBio | 10 mg | EUR 756 |
Description: When compared to other caspase inhibitors, Z-DRHD-FMK inhibited caspase 6 activity more effectively than the general caspase inhibitor Z-Val-Ala-Asp (OMe)-fluoromethy ketone (Z-VAD-FMK) or the caspase 6 inhibitor Z-Val-Glu(Ome)-Ile-Asp(OMe)-fluoromethyl ketone (Z-VEID-FMK). |
Z-VEID-FMK |
|||
A1923-25 | ApexBio | 25 mg | EUR 1173.6 |
Description: When compared to other caspase inhibitors, Z-DRHD-FMK inhibited caspase 6 activity more effectively than the general caspase inhibitor Z-Val-Ala-Asp (OMe)-fluoromethy ketone (Z-VAD-FMK) or the caspase 6 inhibitor Z-Val-Glu(Ome)-Ile-Asp(OMe)-fluoromethyl ketone (Z-VEID-FMK). |
Z-VEID-FMK |
|||
A1923-5 | ApexBio | 5 mg | EUR 477.6 |
Description: When compared to other caspase inhibitors, Z-DRHD-FMK inhibited caspase 6 activity more effectively than the general caspase inhibitor Z-Val-Ala-Asp (OMe)-fluoromethy ketone (Z-VAD-FMK) or the caspase 6 inhibitor Z-Val-Glu(Ome)-Ile-Asp(OMe)-fluoromethyl ketone (Z-VEID-FMK). |
Z-VEID-FMK |
|||
A1923-S | ApexBio | Evaluation Sample | EUR 97.2 |
Description: When compared to other caspase inhibitors, Z-DRHD-FMK inhibited caspase 6 activity more effectively than the general caspase inhibitor Z-Val-Ala-Asp (OMe)-fluoromethy ketone (Z-VAD-FMK) or the caspase 6 inhibitor Z-Val-Glu(Ome)-Ile-Asp(OMe)-fluoromethyl ketone (Z-VEID-FMK). |
Z-WEHD-FMK |
|||
A1924-1 | ApexBio | 1 mg | EUR 135.6 |
Description: Treatment of infected cells with pan-caspase inhibitor IV and Z-WEHD-FMK, an inhibitor of inflammatory caspases, elicited a near-complete blockage of C. trachomatis-induced cleavage of golgin-84. |
Z-WEHD-FMK |
|||
A1924-10 | ApexBio | 10 mg | EUR 408 |
Description: Treatment of infected cells with pan-caspase inhibitor IV and Z-WEHD-FMK, an inhibitor of inflammatory caspases, elicited a near-complete blockage of C. trachomatis-induced cleavage of golgin-84. |
Z-WEHD-FMK |
|||
A1924-25 | ApexBio | 25 mg | EUR 616.8 |
Description: Treatment of infected cells with pan-caspase inhibitor IV and Z-WEHD-FMK, an inhibitor of inflammatory caspases, elicited a near-complete blockage of C. trachomatis-induced cleavage of golgin-84. |
Z-WEHD-FMK |
|||
A1924-5 | ApexBio | 5 mg | EUR 268.8 |
Description: Treatment of infected cells with pan-caspase inhibitor IV and Z-WEHD-FMK, an inhibitor of inflammatory caspases, elicited a near-complete blockage of C. trachomatis-induced cleavage of golgin-84. |
Z-AEVD-FMK |
|||
B1162-1 | Biovision | EUR 405.6 |
Z-VRPR-FMK |
|||
B1238-1000 | Biovision | EUR 1096.8 |
Z-VRPR-FMK |
|||
B1238-250 | Biovision | EUR 405.6 |
Z-IETD-FMK |
|||
B3232-1 | ApexBio | 1 mg | EUR 393.6 |
Description: Z-IETD-FMK is an inhibitor of caspase 8 [1].Z-IETD-FMK inhibits T cell proliferation induced by PHA or anti-CD3 plus anti-CD28 without toxicity of resting T cells. |
Z-IETD-FMK |
|||
B3232-5 | ApexBio | 5 mg | EUR 547.2 |
Description: Z-IETD-FMK is an inhibitor of caspase 8 [1].Z-IETD-FMK inhibits T cell proliferation induced by PHA or anti-CD3 plus anti-CD28 without toxicity of resting T cells. |
Z-IETD-FMK |
|||
B3232-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 1201.2 |
Description: Z-IETD-FMK is an inhibitor of caspase 8 [1].Z-IETD-FMK inhibits T cell proliferation induced by PHA or anti-CD3 plus anti-CD28 without toxicity of resting T cells. |
Z-LEHD-FMK |
|||
B3233-1 | ApexBio | 1 mg | EUR 420 |
Description: Z-LEHD-FMK is a specific and irreversible inhibitor of caspase-9 [1].Caspase-9 is an initiator caspase and plays an important role in the mitochondrial death pathway. |
Z-LEHD-FMK |
|||
B3233-5 | ApexBio | 5 mg | EUR 1054.8 |
Description: Z-LEHD-FMK is a specific and irreversible inhibitor of caspase-9 [1].Caspase-9 is an initiator caspase and plays an important role in the mitochondrial death pathway. |
Z-VRPR-FMK |
|||
GL3755-1MG | Glentham Life Sciences | 1 mg | EUR 702 |
Z-VRPR-FMK |
|||
GL3755-500UG | Glentham Life Sciences | 500 ug | EUR 426 |
Z-IETD-FMK |
|||
HY-101297 | MedChemExpress | 5mg | EUR 555.6 |
Z-DEVD-FMK |
|||
HY-12466 | MedChemExpress | 10mg | EUR 471.6 |
Z-DEVD-FMK |
|||
13303 | AAT Bioquest | 1 mg | EUR 102 |
Z-IETD-FMK |
|||
13305 | AAT Bioquest | 1 mg | EUR 102 |
Z-LETD-FMK |
|||
13307 | AAT Bioquest | 1 mg | EUR 102 |
Calpain Inhibitor, Z-LLY-FMK |
|||
B1506-1000 | Biovision | EUR 405.6 |
Calpain Inhibitor, Z-LLY-FMK |
|||
B1506-250 | Biovision | EUR 261.6 |
Caspase-5 Inhibitor Z-WEHD-FMK |
|||
1100-100 | Biovision | EUR 235.2 |
Caspase-5 Inhibitor Z-WEHD-FMK |
|||
1100-20C | Biovision | EUR 235.2 |
Caspase-4 Inhibitor Z-LEVD-FMK |
|||
1108-100 | Biovision | EUR 222 |
Caspase-4 Inhibitor Z-LEVD-FMK |
|||
1108-20C | Biovision | EUR 222 |
EZSolution? Calpain Inhibitor, Z-LLY-FMK |
|||
1125-20C | Biovision | EUR 222 |
EMAP-II Inhibitor Z-ASTD-FMK |
|||
1127-20C | Biovision | EUR 314.4 |
Caspase-3 Inhibitor Z-DEVD-FMK |
|||
1009-100 | Biovision | EUR 248.4 |
Caspase-3 Inhibitor Z-DEVD-FMK |
|||
1009-20C | Biovision | EUR 248.4 |
Caspase-6 Inhibitor Z-VEID-FMK |
|||
1011-100 | Biovision | EUR 222 |
Caspase-6 Inhibitor Z-VEID-FMK |
|||
1011-20C | Biovision | EUR 222 |
Caspase-1 Inhibitor Z-YVAD-FMK |
|||
1012-100 | Biovision | EUR 235.2 |
Caspase-1 Inhibitor Z-YVAD-FMK |
|||
1012-20C | Biovision | EUR 235.2 |
Caspase-8 Inhibitor Z-IETD-FMK |
|||
1064-100 | Biovision | EUR 235.2 |
Caspase-8 Inhibitor Z-IETD-FMK |
|||
1064-20C | Biovision | EUR 235.2 |
Caspase-2 Inhibitor Z-VDVAD-FMK |
|||
1073-100 | Biovision | EUR 222 |
Caspase-2 Inhibitor Z-VDVAD-FMK |
|||
1073-20C | Biovision | EUR 222 |
Caspase-9 Inhibitor Z-LEHD-FMK |
|||
1074-100 | Biovision | EUR 248.4 |
Caspase-9 Inhibitor Z-LEHD-FMK |
|||
1074-20C | Biovision | EUR 248.4 |
Caspase-12 Inhibitor Z-ATAD-FMK |
|||
1079-100 | Biovision | EUR 261.6 |
Caspase-12 Inhibitor Z-ATAD-FMK |
|||
1079-20C | Biovision | EUR 261.6 |
Caspase-3 inhibitor, Z-DQMD-FMK |
|||
2782-1 | Biovision | EUR 170.4 |
Caspase-3 inhibitor, Z-DQMD-FMK |
|||
2782-5 | Biovision | EUR 496.8 |
Caspase-8 Inhibitor Z-IETD-FMK |
|||
B4096-.02 | ApexBio | 20 µl (10 mM) | EUR 234 |
Description: Z-IETD-FMK is an inhibitor of caspase 8 [1].Z-IETD-FMK inhibits T cell proliferation induced by PHA or anti-CD3 plus anti-CD28 without toxicity of resting T cells. |
Caspase-8 Inhibitor Z-IETD-FMK |
|||
B4096-.1 | ApexBio | 100 µl (2 mM) | EUR 234 |
Description: Z-IETD-FMK is an inhibitor of caspase 8 [1].Z-IETD-FMK inhibits T cell proliferation induced by PHA or anti-CD3 plus anti-CD28 without toxicity of resting T cells. |
Caspase-9 Inhibitor Z-LEHD-FMK |
|||
B4573-.02 | ApexBio | 20 µl (10 mM) | EUR 234 |
Description: Z-LEHD-FMK is a specific and irreversible inhibitor of caspase-9 [1]. Caspase-9 is an initiator caspase and plays an important role in the mitochondrial death pathway. |
Caspase-9 Inhibitor Z-LEHD-FMK |
|||
B4573-.1 | ApexBio | 100 µl (2 mM) | EUR 234 |
Description: Z-LEHD-FMK is a specific and irreversible inhibitor of caspase-9 [1]. Caspase-9 is an initiator caspase and plays an important role in the mitochondrial death pathway. |
Cathepsin B&L Inhibitor Z-Phe-Phe-FMK |
|||
1126-20C | Biovision | EUR 274.8 |
FMK |
|||
A3420-10 | ApexBio | 10 mg | EUR 447.6 |
Description: FMK is a potent, highly specific and irreversible ribosomal s6 kinase (RSK) inhibitor with IC50 value of 15 nM.[1]RSK is named for ribosomal protein s6, part of the translational machinery which are serine/threonine kinases and are activated by the MAPK/ERK pathway. |
FMK |
|||
HY-52101A | MedChemExpress | 10mM/1mL | EUR 403.2 |
Anti-DYKDDDDK Antibody | CFLG-45A-Z |
|||
CFLG-45A-Z | Immunology Consultants Laboratory | 0.1 mg | EUR 348 |
Description: Anti-DYKDDDDK Antibody | CFLG-45A-Z | Immunology Consultants Laboratory Host: Chicken Format: Unconjugated AP Product Type: Primary Antibody Antibody Clonality: Polyclonal |
Anti-DYKDDDDK Antibody | CFLG-45F-Z |
|||
CFLG-45F-Z | Immunology Consultants Laboratory | 0.1 mg | EUR 363 |
Description: Anti-DYKDDDDK Antibody | CFLG-45F-Z | Immunology Consultants Laboratory Host: Chicken Format: FITC Conjugated Product Type: Primary Antibody Antibody Clonality: Polyclonal |
Anti-DYKDDDDK Antibody | CFLG-45P-Z |
|||
CFLG-45P-Z | Immunology Consultants Laboratory | 0.1 mg | EUR 379 |
Description: Anti-DYKDDDDK Antibody | CFLG-45P-Z | Immunology Consultants Laboratory Host: Chicken Format: HRP Conjugated Product Type: Primary Antibody Antibody Clonality: Polyclonal |
Anti-GFP Antibody | CGFP-45A-Z |
|||
CGFP-45A-Z | Immunology Consultants Laboratory | 0.1 mg | EUR 308 |
Description: Anti-GFP Antibody | CGFP-45A-Z | Immunology Consultants Laboratory Host: Chicken Format: Unconjugated AP Product Type: Primary Antibody Antibody Clonality: Polyclonal |
Anti-HA Antibody | CHGT-45A-Z |
|||
CHGT-45A-Z | Immunology Consultants Laboratory | 0.1 mg | EUR 348 |
Description: Anti-HA Antibody | CHGT-45A-Z | Immunology Consultants Laboratory Host: Chicken Format: Unconjugated AP Product Type: Primary Antibody Antibody Clonality: Polyclonal |
Anti-HA Antibody | CHGT-45F-Z |
|||
CHGT-45F-Z | Immunology Consultants Laboratory | 0.1 mg | EUR 363 |
Description: Anti-HA Antibody | CHGT-45F-Z | Immunology Consultants Laboratory Host: Chicken Format: FITC Conjugated Product Type: Primary Antibody Antibody Clonality: Polyclonal |
Anti-HA Antibody | CHGT-45P-Z |
|||
CHGT-45P-Z | Immunology Consultants Laboratory | 0.1 mg | EUR 379 |
Description: Anti-HA Antibody | CHGT-45P-Z | Immunology Consultants Laboratory Host: Chicken Format: HRP Conjugated Product Type: Primary Antibody Antibody Clonality: Polyclonal |
Anti-CHO PLBL2 | GPLB-65B-Z |
|||
GPLB-65B-Z | Immunology Consultants Laboratory | 0.1 mg | EUR 969 |
Description: Anti-CHO PLBL2 | GPLB-65B-Z | Immunology Consultants Laboratory Host: Goat Format: Biotin Conjugated Product Type: Primary Antibody Antibody Clonality: Polyclonal |
Anti-DYKDDDDK Antibody | MFLG-45A-Z |
|||
MFLG-45A-Z | Immunology Consultants Laboratory | 0.1 mg | EUR 348 |
Description: Anti-DYKDDDDK Antibody | MFLG-45A-Z | Immunology Consultants Laboratory Host: Mouse Format: Unconjugated AP Product Type: Primary Antibody Antibody Clonality: Polyclonal |
Anti-DYKDDDDK Antibody | RFLG-45A-Z |
|||
RFLG-45A-Z | Immunology Consultants Laboratory | 0.1 mg | EUR 348 |
Description: Anti-DYKDDDDK Antibody | RFLG-45A-Z | Immunology Consultants Laboratory Host: Rabbit Format: Unconjugated AP Product Type: Primary Antibody Antibody Clonality: Polyclonal |
Anti-DYKDDDDK Antibody | RFLG-45B-Z |
|||
RFLG-45B-Z | Immunology Consultants Laboratory | 0.1 mg | EUR 363 |
Description: Anti-DYKDDDDK Antibody | RFLG-45B-Z | Immunology Consultants Laboratory Host: Rabbit Format: Biotin Conjugated Product Type: Primary Antibody Antibody Clonality: Polyclonal |
Anti-DYKDDDDK Antibody | RFLG-45F-Z |
|||
RFLG-45F-Z | Immunology Consultants Laboratory | 0.1 mg | EUR 363 |
Description: Anti-DYKDDDDK Antibody | RFLG-45F-Z | Immunology Consultants Laboratory Host: Rabbit Format: FITC Conjugated Product Type: Primary Antibody Antibody Clonality: Polyclonal |
Anti-DYKDDDDK Antibody | RFLG-45P-Z |
|||
RFLG-45P-Z | Immunology Consultants Laboratory | 0.1 mg | EUR 379 |
Description: Anti-DYKDDDDK Antibody | RFLG-45P-Z | Immunology Consultants Laboratory Host: Rabbit Format: HRP Conjugated Product Type: Primary Antibody Antibody Clonality: Polyclonal |
Anti-GFP Antibody | RGFP-45A-Z |
|||
RGFP-45A-Z | Immunology Consultants Laboratory | 0.1 mg | EUR 355 |
Description: Anti-GFP Antibody | RGFP-45A-Z | Immunology Consultants Laboratory Host: Rabbit Format: Unconjugated AP Product Type: Primary Antibody Antibody Clonality: Polyclonal |
Anti-GST Antibody | RGST-45A-Z |
|||
RGST-45A-Z | Immunology Consultants Laboratory | 0.1 mg | EUR 197 |
Description: Anti-GST Antibody | RGST-45A-Z | Immunology Consultants Laboratory Host: Rabbit Format: Unconjugated AP Product Type: Primary Antibody Antibody Clonality: Polyclonal |
Anti-GST Antibody | RGST-45B-Z |
|||
RGST-45B-Z | Immunology Consultants Laboratory | 0.1 mg | EUR 268 |
Description: Anti-GST Antibody | RGST-45B-Z | Immunology Consultants Laboratory Host: Rabbit Format: Biotin Conjugated Product Type: Primary Antibody Antibody Clonality: Polyclonal |
Anti-GST Antibody | RGST-45F-Z |
|||
RGST-45F-Z | Immunology Consultants Laboratory | 0.1 mg | EUR 268 |
Description: Anti-GST Antibody | RGST-45F-Z | Immunology Consultants Laboratory Host: Rabbit Format: FITC Conjugated Product Type: Primary Antibody Antibody Clonality: Polyclonal |
Anti-GST Antibody | RGST-45P-Z |
|||
RGST-45P-Z | Immunology Consultants Laboratory | 0.1 mg | EUR 308 |
Description: Anti-GST Antibody | RGST-45P-Z | Immunology Consultants Laboratory Host: Rabbit Format: HRP Conjugated Product Type: Primary Antibody Antibody Clonality: Polyclonal |
Anti-HA Antibody | RHGT-145D-Z |
|||
RHGT-145D-Z | Immunology Consultants Laboratory | 0.2 mL | EUR 363 |
Description: Anti-HA Antibody | RHGT-145D-Z | Immunology Consultants Laboratory Host: Rabbit Format: Agarose Immobilized Product Type: Primary Antibody Antibody Clonality: Polyclonal |
Anti-HA Antibody | RHGT-45A-Z |
|||
RHGT-45A-Z | Immunology Consultants Laboratory | 0.1 mg | EUR 348 |
Description: Anti-HA Antibody | RHGT-45A-Z | Immunology Consultants Laboratory Host: Rabbit Format: Unconjugated AP Product Type: Primary Antibody Antibody Clonality: Polyclonal |
Anti-HA Antibody | RHGT-45B-Z |
|||
RHGT-45B-Z | Immunology Consultants Laboratory | 0.1 mg | EUR 363 |
Description: Anti-HA Antibody | RHGT-45B-Z | Immunology Consultants Laboratory Host: Rabbit Format: Biotin Conjugated Product Type: Primary Antibody Antibody Clonality: Polyclonal |
Anti-HA Antibody | RHGT-45F-Z |
|||
RHGT-45F-Z | Immunology Consultants Laboratory | 0.1 mg | EUR 363 |
Description: Anti-HA Antibody | RHGT-45F-Z | Immunology Consultants Laboratory Host: Rabbit Format: FITC Conjugated Product Type: Primary Antibody Antibody Clonality: Polyclonal |